Alaethes Wealth LLC lessened its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 4.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,590 shares of the exchange traded fund’s stock after selling 290 shares during the period. Alaethes Wealth LLC’s holdings in SPDR S&P Biotech ETF were worth $518,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. ICA Group Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $27,000. Scarborough Advisors LLC acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter worth $32,000. BOCHK Asset Management Ltd acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter worth $36,000. ORG Partners LLC bought a new stake in SPDR S&P Biotech ETF in the second quarter valued at $40,000. Finally, Vima LLC acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $45,000.
SPDR S&P Biotech ETF Stock Performance
Shares of NYSEARCA:XBI opened at $101.61 on Friday. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52. The business’s 50 day simple moving average is $99.03 and its two-hundred day simple moving average is $93.98. The firm has a market cap of $7.74 billion, a P/E ratio of 11.47 and a beta of 1.11.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- How to Capture the Benefits of Dividend Increases
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Investing in the High PE Growth Stocks
- MarketBeat Week in Review – 9/16 – 9/20
- How is Compound Interest Calculated?
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
